Marathon Asset Management
http://www.marathonfund.com/index.phpMarathon Asset Management is a global asset management and alternative investment company. The firm specializes in global debt including high yield, bank debt, distressed debt, emerging market debt, convertible bonds, special situations, structured finance, structured debt transactions and real estate opportunities and investments. The firm was founded in 1998.
View Older Stories View More Recent Stories
-
Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates
-
Marathon Asset Management Closes $1.7 Billion Asset-Based Lending Fund
-
Form 3 ATI Physical Therapy, For: Jun 15 Filed by: MARATHON ASSET MANAGEMENT LP
-
Form SC 13D ATI Physical Therapy, Filed by: Marathon Asset Management GP, L.L.C.
-
Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management
-
Madison Realty Capital Names Wilma Nacion Chief Human Resources Officer
-
John Hancock Investment Management expands alternatives availability and reach for investors
-
Marathon Asset Management Announces New Partner
-
Holding(s) in Company
-
Marathon Asset Management Adds a Senior Investor Relations Professional Focused on Institutional Consultants
-
Theratechnologies (THTX) Reports Q1 Results and Business Update
-
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
-
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
-
Marathon Asset Management Adds Senior Investor Relations Professionals
-
Holding(s) in Company
-
Marathon Asset Management Appoints Curt Lueker to Lead Marathon’s Direct Lending Business
-
Nissan downgrade seen as start of 'fallen angels' cycle
-
Marathon Asset Management Closes $400 Million New Issue Collateralized Loan Obligation
-
Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
-
Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
-
Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
-
Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
-
Form SC 13G/A Upland Software, Inc. Filed by: Marathon Asset Management Ltd
-
Acer Therapeutics (ACER) and Relief Announce FDA Approval of OLPRUVA
-
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
-
Private debt markets face reality check as companies grapple with rising rates, recession
-
Marathon Asset Management Closes Inaugural Aircraft Securitization
-
Marathon Asset Management, L.P. ('Marathon') closes Aircraft ABS Transaction with Airborne Capital Limited ('Airborne Capital') serving as advisor and servicer
-
Analysis-U.S. junk bond investors face tough choice as yields spike
-
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
-
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
-
Longtime Capital Markets Executive Charles Short Joins AE Industrial Partners as Managing Director and Head of Capital Formation
-
Marathon Asset Management Appoints Karen Lau as Senior Portfolio Manager
-
Brian Schwartz Named Chief Investment Officer at Mi BANK
-
Form SC 13G John Hancock Asset-Based Filed by: MARATHON ASSET MANAGEMENT LP
-
Vanguard Canada Announces Changes to Vanguard Global Equity Fund
-
Vanguard Announces Advisory Changes for Vanguard Global Equity Fund
-
Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement
-
Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement
-
Form 3 John Hancock Asset-Based For: Jul 11 Filed by: MARATHON ASSET MANAGEMENT LP
-
Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update
-
Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update
-
Theratechnologies (THTX) Enter Binding Commitment for Non-Dilutive Term Loan of up to $100M Marathon Asset Management
-
Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management
-
Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management
-
John Hancock Investment Management partners with Marathon Asset Management to expand alternatives offerings for accredited investors with Asset-Based Lending Fund
-
Acer Therapeutics Reports Q1 2022 Financial Results and Provides Corporate Update
-
Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilities
-
LSTA Publishes Industry Handbook on Loan Syndications and Trading
-
Holding(s) in Company

